INSTANT PORRIDGE COMPOSITION OF THE FUNCTIONAL PURPOSE: TECHNOLOGICAL ASPECTS
DOI:
https://doi.org/10.15673/2073-8684.4/2015.55874Kulcsszavak:
instant porridges, collagen preparation, glutin, compositional mixtures, mathematical modeling, extrusionAbsztrakt
The objective of the research is to develop compositions and technology of dry compositional mixtures with glutin inclusion for producing instant porridges of functional purpose. The method of mathematical modeling was applied to develop compositional mixtures.
The alkaline hydrolysis method was used to obtain collagen preparation (glutin) from the fish industry derivative products. To establish the biological value of the developed instant porridges ion-exchange chromatographing (Hitachi 835) was used.
It is shown, that the inclusion of glutin in developed mixtures contributes to the biological value of culinary products and provides additional functional properties. The biological full-value of developed instant porridges is determined. It is established that the degree of the daily requirement satisfaction of essential amino acids is 30 %, when consumed the recommended servings of food. Examined organoleptic, rheological and physicochemical characteristics of developed products confirm the usefulness of the proposed technology.
Hivatkozások
Molchanova EN, Suslyanok GM Ocenka kachestva i znachenie pishevyh belkov. Hranenie i pererabotka sel'hozsyr'ya. 2013; 1: 16-22.
Cipriyan VI, Matasar IT, Slobodkin VI Gigiena harchuvannya z osnovami nutriciologia. K.: Medicina. 2007; 544.
Nechaev AP, Traunberberg SE, Kochetkova AA i dr. Pishevaya himiya. SPb.: GIORD.2001; 640.
Lishenko VF Mirovye resursy pishevogo belka. Pishevye ingredienty. Syr'e i dobavki. 2003; 1: 12-15.
Rogov IA,. Antipova LV, Dunchenko NI i dr Himiya pishi. Belki: struktura, funkcii, rol' v pitanii. M.: Kolos. 2000; 384.
Neklyudov AD Vydelenie kollagenov iz organov i tkanei mlekopitayushih. Ekologicheskie sistemy i pribory. 2005; 11: 24-26.
Kazakov ED, Kretovich VL Biohimiya zerna i produktov ego pererabotki.M.: Agropromizdat, 1989; 368.
Patent Ukrainy na korysnu model' № 79357. MPK A23 J 1/04 (2006.01.01)./ Sposib oderzhannja kolagenovogo preparatu / Telezhenko L.M., Kushnir N.A.– № u201209751; Zajavl. 13.08.2012; Opubl. 25.04.2013, Bjul. № 8.
Kushnir NA Vyznachennja zbalansovanosti aminokyslotnogo skladu kolagenovogo preparatu. Progresyvni tehnika ta tehnologii' harchovyh vyrobnyctv restorannogo gospodarstva i torgivli: Zb. nauk. prac': v 2 ch. Ch.2 / Hark. derzh. un-t harchuvannja ta torgivli. Harkiv. 2014; 1 (19): 107-116.
Patent Ukrainy na korysnu model' № 85877. MPK (2006.01) A23L 1/18 / Kompozycija zernovoi' kashi «Bodrost'»/ Telezhenko L.M., Kushnir N.A., Kashkano M.A. – № u201304300; zajavl. 05.04.2013; opubl. 10.12.2013, bjul. № 23/2013.
Reich G. Die Nutzung von Kollagen ausserhalb der Lederindustrie. Teil II. Spezialle Einsatsgebiete Kollagenhochveredlung. Leder. 1995; 46 (2): 18-27.
Moskowitz RW Role of collagen hydrolysate in bone and joint disease. Seminars in Arthritis and Rheumatism. 2000; 30: 87-99.
Liu Z.-Y, D. Chen D, Su Y.-C, and Zeng M-Y Optimization of hydrolysis conditions for the production of the angiotensin-I converting enzyme inhibitory peptides from sea cucumber collagen hydrolysates. J. Aquat. Food Prod. Technol. 2011; 20: 222-232.
Liu F, Liub C, Lorenac D et al. Evaluation of the antioxidant activity of collagen peptide additive extracted from cod skin. J. Environ. Protect. Ecology. 2012; 13: 1836-1841.
Yu P and Chen H Optimization of conditions for enzymatic production collagen hydrolysates from a long-value acaudinamolpadioides and their activites. J. Food Biochem. 2013; 38: 227-235.
Lopez HL Osteoarthritis supplement nutritional interventions to prevent and treat osteoarthritis. Part II: Focus on vicronutrients and supportive nutraceuticals. Amer. Acad. Physic. Med. Rehab. 2012; 4: 155-168.
Browder IW, Litwin MS. Use of absorbable collagen for hemostasis in general surgical patients/ Am. Surg. 1986; 52 (9): 492-494.
DeLustro F, Dasch J, Keefe J, Ellingsworth L Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin. Orthop. 1990; 260: 263-279.
Evans BE Local hemostatic agents (and techniques). Scand. J. Haematol. 1984; 33 (40): 417.
Bloom AL, Thomas DP Haemostasis and Thrombosis. London: Churchill Livingstone. 1987: 614-615.
